NO20030596L - Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number: NO20030596L
Authority: NO; Norway
Prior art keywords: preparation; therapeutic use; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2000-08-08

Application number

NO20030596A

Other languages

English (en)

Other versions

NO20030596D0 (no

Inventor

Francis Barth

Daniel Bichon

Frank Bolkenius

Viviane Van Dorsselaer

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-08

Filing date

2003-02-06

Publication date

2003-04-01

2000-08-08 Priority claimed from FR0010419A external-priority patent/FR2812878B1/fr

2000-11-15 Priority claimed from FR0014696A external-priority patent/FR2816619B1/fr

2003-02-06 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2003-02-06 Publication of NO20030596D0 publication Critical patent/NO20030596D0/no

2003-04-01 Publication of NO20030596L publication Critical patent/NO20030596L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Hematology (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)

NO20030596A 2000-08-08 2003-02-06 Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse NO20030596L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0010419A FR2812878B1 (fr)	2000-08-08	2000-08-08	Derives de benzimidazole, leur preparation et leur application en therapeutique
FR0014696A FR2816619B1 (fr)	2000-11-15	2000-11-15	Derives de benzimidazole, leur preparation et leur application en therapeutique
PCT/FR2001/002556 WO2002012239A1 (fr)	2000-08-08	2001-08-06	Derives de benzimidazole, leur preparation et leur application en therapeutique

Publications (2)

Publication Number	Publication Date
NO20030596D0 NO20030596D0 (no)	2003-02-06
NO20030596L true NO20030596L (no)	2003-04-01

Family

ID=26212570

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030596A NO20030596L (no)	2000-08-08	2003-02-06	Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse

Country Status (28)

Country	Link
US (2)	US6794382B2 (no)
EP (1)	EP1309594B1 (no)
JP (1)	JP2004505975A (no)
KR (1)	KR20030020450A (no)
CN (1)	CN1446218A (no)
AR (1)	AR030121A1 (no)
AT (1)	ATE284886T1 (no)
AU (1)	AU2001282267A1 (no)
BG (1)	BG107460A (no)
BR (1)	BR0113046A (no)
CA (1)	CA2412368A1 (no)
CZ (1)	CZ294493B6 (no)
DE (1)	DE60107859T2 (no)
EA (1)	EA005950B1 (no)
EE (1)	EE200300048A (no)
ES (1)	ES2233671T3 (no)
HK (1)	HK1053118A1 (no)
HR (1)	HRP20030081A2 (no)
HU (1)	HUP0301514A2 (no)
IL (1)	IL153708A0 (no)
IS (1)	IS6661A (no)
MX (1)	MXPA03000753A (no)
NO (1)	NO20030596L (no)
PL (1)	PL365080A1 (no)
PT (1)	PT1309594E (no)
SK (1)	SK1582003A3 (no)
WO (1)	WO2002012239A1 (no)
YU (1)	YU7203A (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
US20040014744A1 (en) *	2002-04-05	2004-01-22	Fortuna Haviv	Substituted pyridines having antiangiogenic activity
AU2003240742A1 (en) *	2002-06-07	2003-12-22	Altana Pharma Ag	4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors
AU2003236686A1 (en) *	2002-06-07	2003-12-22	Altana Pharma Ag	4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors
WO2004108723A1 (en) *	2003-06-04	2004-12-16	Altana Pharma Ag	4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors
GB0317466D0 (en) *	2003-07-25	2003-08-27	Univ Sheffield	Use
HUE025996T2 (en)	2003-12-01	2016-05-30	Kudos Pharm Ltd	Inhibitors of DNA damage repair for the treatment of cancer
EP1827438B2 (en) *	2004-09-20	2014-12-10	Xenon Pharmaceuticals Inc.	Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
AR051091A1 (es) *	2004-09-20	2006-12-20	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
TW200626154A (en)	2004-09-20	2006-08-01	Xenon Pharmaceuticals Inc	Heterocyclic derivatives and their use as therapeutic agents
AR051202A1 (es) *	2004-09-20	2006-12-27	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CN101083992A (zh) *	2004-09-20	2007-12-05	泽农医药公司	抑制人硬脂酰CoA去饱和酶的哒嗪衍生物
EP1804799B1 (en) *	2004-09-20	2013-08-21	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1799667B1 (en) *	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
WO2006034312A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd)
EP2289510A1 (en)	2004-09-20	2011-03-02	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
DE602006018255D1 (de) *	2005-01-11	2010-12-30	Neurosearch As	Neue 2-amino-benzimidazolderivate und ihre verwendung als modulatoren calciumaktivierter kaliumkanäle mit geringer leitfähigkeit
AU2006343359A1 (en) *	2005-06-03	2007-11-15	Xenon Pharmaceuticals Inc.	Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
BRPI0614168A2 (pt) *	2005-08-05	2017-07-25	Astrazeneca Ab	Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto
US20090239880A1 (en) *	2006-07-03	2009-09-24	Ulrik Svane Sorensen	Combinations of monoamine reuptake inhibitors and potassium channel activators
GB0716532D0 (en)	2007-08-24	2007-10-03	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB201220157D0 (en)	2012-11-08	2012-12-26	Selvita Sa	Substitute tricyclic benzimidazoles as kinase inhibitors
CN103923088B (zh) *	2013-01-11	2016-09-07	上海汇伦生命科技有限公司	2,5-二氮杂双环[2.2.1]庚烷类化合物和制备方法、其药用组合物及其在医药上的应用
KR102216288B1 (ko)	2013-03-15	2021-02-18	인사이트 홀딩스 코포레이션	Bet 단백질 저해제로서의 삼환식 복소환
CN104230896A (zh) *	2013-06-17	2014-12-24	上海汇伦生命科技有限公司	苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途
WO2015095492A1 (en)	2013-12-19	2015-06-25	Incyte Corporation	Tricyclic heterocycles as bet protein inhibitors
CA2946731C (en)	2014-04-23	2022-06-07	Incyte Corporation	1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
TWI700284B (zh) *	2015-05-29	2020-08-01	日商塩野義製藥股份有限公司	具有ｈｉｖ複製抑制作用之含氮３環性衍生物
UA125476C2 (uk)	2016-06-20	2022-03-23	Інсайт Корпорейшн	Спосіб отримання 2,2,4-триметил-8-(6-метил-7-оксо-6,7-дигідро-1н-піроло[2,3-c]піридин-4-іл)-6-(метилсульфоніл)-2н-бензо[b][1,4]оксазин-3(4н)-ону і проміжних сполук
CN110661676B (zh) *	2018-06-29	2022-06-28	大唐移动通信设备有限公司	一种带宽部分的测量方法、配置方法、终端及网络设备
CN111349094B (zh) *	2020-04-23	2021-02-02	杭州师范大学	一种6H-咪唑[4,5,1-ij]并喹诺酮及其合成方法和应用
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2710915B1 (fr)	1993-10-04	1995-11-24	Synthelabo	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
FR2731708B1 (fr)	1995-03-13	1997-04-30	Synthelabo	Derives de piperidine, leur procede de preparation et leur application en therapeutique
DK1133477T3 (da)	1998-11-27	2004-06-21	Abbott Gmbh & Co Kg	Substituerede benzimidazoler og deres anvendelse som parpinhibitorer

2001
- 2001-08-06 CZ CZ2003354A patent/CZ294493B6/cs not_active IP Right Cessation
- 2001-08-06 HU HU0301514A patent/HUP0301514A2/hu unknown
- 2001-08-06 BR BR0113046-3A patent/BR0113046A/pt not_active IP Right Cessation
- 2001-08-06 EE EEP200300048A patent/EE200300048A/xx unknown
- 2001-08-06 WO PCT/FR2001/002556 patent/WO2002012239A1/fr active IP Right Grant
- 2001-08-06 IL IL15370801A patent/IL153708A0/xx unknown
- 2001-08-06 CN CN01813895A patent/CN1446218A/zh active Pending
- 2001-08-06 SK SK158-2003A patent/SK1582003A3/sk unknown
- 2001-08-06 MX MXPA03000753A patent/MXPA03000753A/es unknown
- 2001-08-06 JP JP2002518214A patent/JP2004505975A/ja active Pending
- 2001-08-06 AU AU2001282267A patent/AU2001282267A1/en not_active Abandoned
- 2001-08-06 PL PL01365080A patent/PL365080A1/xx not_active Application Discontinuation
- 2001-08-06 EA EA200201259A patent/EA005950B1/ru not_active IP Right Cessation
- 2001-08-06 AR ARP010103751A patent/AR030121A1/es not_active Application Discontinuation
- 2001-08-06 CA CA002412368A patent/CA2412368A1/fr not_active Abandoned
- 2001-08-06 US US10/343,467 patent/US6794382B2/en not_active Expired - Fee Related
- 2001-08-06 ES ES01960871T patent/ES2233671T3/es not_active Expired - Lifetime
- 2001-08-06 EP EP01960871A patent/EP1309594B1/fr not_active Expired - Lifetime
- 2001-08-06 DE DE60107859T patent/DE60107859T2/de not_active Expired - Lifetime
- 2001-08-06 PT PT01960871T patent/PT1309594E/pt unknown
- 2001-08-06 KR KR10-2003-7001760A patent/KR20030020450A/ko not_active Application Discontinuation
- 2001-08-06 AT AT01960871T patent/ATE284886T1/de not_active IP Right Cessation
- 2001-08-06 YU YU7203A patent/YU7203A/sh unknown
2002
- 2002-12-19 IS IS6661A patent/IS6661A/is unknown
2003
- 2003-01-14 BG BG107460A patent/BG107460A/bg unknown
- 2003-02-06 HR HR20030081A patent/HRP20030081A2/hr not_active Application Discontinuation
- 2003-02-06 NO NO20030596A patent/NO20030596L/no not_active Application Discontinuation
- 2003-07-28 HK HK03105435A patent/HK1053118A1/xx not_active IP Right Cessation
2004
- 2004-09-13 US US10/939,910 patent/US20050032779A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1309594E (pt)	2005-04-29
AU2001282267A1 (en)	2002-02-18
NO20030596D0 (no)	2003-02-06
BR0113046A (pt)	2003-07-01
HK1053118A1 (en)	2003-10-10
WO2002012239A1 (fr)	2002-02-14
HRP20030081A2 (en)	2005-02-28
KR20030020450A (ko)	2003-03-08
EE200300048A (et)	2004-12-15
YU7203A (sh)	2006-01-16
EP1309594B1 (fr)	2004-12-15
AR030121A1 (es)	2003-08-13
IS6661A (is)	2002-12-19
US6794382B2 (en)	2004-09-21
CN1446218A (zh)	2003-10-01
EP1309594A1 (fr)	2003-05-14
PL365080A1 (en)	2004-12-27
DE60107859T2 (de)	2005-12-22
JP2004505975A (ja)	2004-02-26
DE60107859D1 (de)	2005-01-20
CZ294493B6 (cs)	2005-01-12
US20030203893A1 (en)	2003-10-30
EA005950B1 (ru)	2005-08-25
CA2412368A1 (fr)	2002-02-14
SK1582003A3 (en)	2003-08-05
IL153708A0 (en)	2003-07-06
BG107460A (bg)	2003-09-30
HUP0301514A2 (hu)	2003-09-29
ATE284886T1 (de)	2005-01-15
CZ2003354A3 (cs)	2003-05-14
EA200201259A1 (ru)	2003-06-26
ES2233671T3 (es)	2005-06-16
US20050032779A1 (en)	2005-02-10
MXPA03000753A (es)	2003-10-15

Publication	Publication Date	Title
NO20030596D0 (no)	2003-02-06	Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
DK1419150T3 (da)	2005-08-29	1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse
DK1177178T3 (da)	2005-05-02	Heterocyclisk substituerede benzimidazoler, deres fremstilling og anvendelse
NO20024742D0 (no)	2002-10-02	Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015156L (no)	2001-12-18	5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DK1161434T3 (da)	2003-05-26	Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20014603L (no)	2001-11-26	Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20031838D0 (no)	2003-04-24	Benzokazinonderivater, deres fremstilling og anvendelse
DK1513835T3 (da)	2006-12-27	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
NO20003773D0 (no)	2000-07-21	Syklobutenderivater, deres fremstilling og deres terapeutiske anvendelser
DK1043307T3 (da)	2003-09-22	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1525193T3 (da)	2008-04-28	Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
NO20032234D0 (no)	2003-05-16	Nye imidazolderivater, deres fremstilling og anvendelse
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
DK1353912T3 (da)	2006-01-09	2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
NO20024107L (no)	2002-09-27	Tienopyridin derivater, deres fremstilling og anvendelse
NO20025209L (no)	2002-10-30	Cyklipostiner, deres fremstilling og anvendelse
NO20001782L (no)	2000-10-09	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1458721T3 (da)	2007-03-26	3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indol-1-carbox-amidderivater, deres fremstilling og terapeutisk anvendelse
DK1309594T3 (da)	2005-04-25	Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf
DK1177196T3 (da)	2004-06-21	Heteroaryldiazabicycloalkaner, deres fremstilling og anvendelse
NO20033118D0 (no)	2003-07-08	Mikanolide-derivater, deres fremstilling og terapeutiske anvendelser

Legal Events

Date	Code	Title	Description
2007-03-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application